Skip to main content
OpenTrials
Completed

NCT Number: NCT05192785

The Effects Incentive Spirometry Use in Coronary Artery Bypass Surgery

Background: Incentive spirometry is used in addition to care, especially in reducing pulmonary complications after surgery. Complications in the cardiovascular and pulmonary systems can basically be determined by blood values and vital signs, which are important objective data of haemodynamics.

Aim: This study was designed to test the hypothesis that the use of incentive spirometry in conjunction with postoperative pulmonary rehabilitation care has a notable impact on arterial blood gas, oxygen saturation (SpO2), and vital signs.

Methods: This randomised, controlled trial was designed using a repeated-measures design. The study was planned to be conducted at the cardiovascular surgery clinic of a university hospital. It was intended that data from patients undergoing coronary artery bypass graft surgery would be analyzed. All patients were planned to receive routine pulmonary rehabilitation, with incentive spirometry added for the experimental group. Outcome measures were designed to include arterial blood gas values, oxygen saturation, and vital signs recorded during the postoperative period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cukurova University

Sarıçam, Adana, Turkey (Türkiye)

About this study

This study was designed as a single-center, randomized controlled trial with repeated measures to evaluate the effects of incentive spirometry used in addition to routine postoperative pulmonary rehabilitation in patients undergoing coronary artery bypass graft surgery.

The study was planned to be conducted in the cardiovascular surgery clinic of a university hospital. Patients assessed for eligibility were to be randomized into two groups: an experimental group (receiving incentive spirometry plus routine pulmonary rehabilitation) or a control group (receiving routine pulmonary rehabilitation only).

Randomization was performed using a simple randomization method with a computer-generated random number table. Group assignments were placed in sequentially numbered sealed envelopes to ensure allocation concealment. A single-blind approach was used during randomization, where the principal investigator and the statistician remained blinded to group assignments.

In the experimental group, it was planned that patients would receive routine pulmonary rehabilitation together with incentive spirometry. The device intended for use was a flow-oriented incentive spirometer with three chambers (target volumes: 600, 900, and 1200 mL). The intervention was planned to be initiated postoperatively after extubation and continued throughout the hospital stay. The procedure involved 10 to 20 deep breaths every 1 to 2 hours, combined with coughing exercises.

The control group was planned to receive routine pulmonary rehabilitation care without incentive spirometry. This care included deep breathing and coughing exercises, pain assessment, and early mobilization. Early mobilization was planned for both groups.

Data collection was planned to be performed during the preoperative period and across the early postoperative period (Days 1, 2, and 3). Recorded variables were intended to include demographic characteristics, arterial blood gas values (PaO2, PaCO2, SaO2), peripheral oxygen saturation (SpO2), and vital signs (systolic/diastolic blood pressure, respiratory rate, and pulse rate).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing first-time, nonemergency coronary artery bypass graft surgery
  • Patients who agreed to participate in the study
  • Patients who were able to communicate

Patients with no hearing difficulty

Patients with no history of psychiatric and/or mental illness

-Patients with a stable clinical condition

Exclusion criteria

  • Patients with an unstable clinical condition
  • Patients who refused to participate
  • Patients with chronic obstructive pulmonary disease
  • Patients with chronic kidney failure
  • Patients with severe hemodynamic dysfunction
  • Patients requiring sternotomy or re-sternotomy
  • Patients requiring prolonged mechanical ventilation

Treatment and study plan

Incentive Spirometry Group

Device

A flow-oriented incentive spirometer with three compartments and target volumes of 600, 900, and 1200 mL was used. Patients were instructed in its use preoperatively and continued the application after extubation when fully awake. The intervention was performed every 1 to 2 hours while awake, for a total of 10 to 20 breaths according to tolerance. Patients performed deep breathing exercises first, followed by incentive spirometry, and then coughing exercises. During the application, the bed was elevated to 45 degrees and the patient was positioned in long sitting. Patients were instructed to inhale slowly and deeply to raise the balls to the target level, hold their breath for 3 to 5 seconds, and then exhale normally. The exercise was repeated according to tolerance, and coughing exercises were performed after every five repetitions.

Primary outcomes

  1. Partial Pressure of Oxygen (PaO2)

    Time frame: Preoperative, postoperative day 1, postoperative day 2, and postoperative day 3

    Measurement of the partial pressure of oxygen (mmHg) obtained via arterial blood gas analysis to evaluate oxygenation levels.

  2. Partial Pressure of Carbon Dioxide (PaCO2)

    Time frame: Preoperative, postoperative day 1, postoperative day 2, and postoperative day 3.

    Measurement of the partial pressure of carbon dioxide (mmHg) obtained via arterial blood gas analysis to evaluate ventilation efficiency.

  3. Arterial Oxygen Saturation (SaO2)

    Time frame: Preoperative, postoperative day 1, postoperative day 2, and postoperative day 3.

    Measurement of the arterial oxygen saturation percentage (%) obtained via arterial blood gas analysis.

  4. Peripheral Oxygen Saturation (SpO2)

    Time frame: Preoperative, postoperative day 1, postoperative day 2, and postoperative day 3.

    Measurement of the peripheral oxygen saturation percentage (%) using a non-invasive pulse oximetry device.

Secondary outcomes

  1. Change in Systolic Blood Pressure

    Time frame: Preoperative, postoperative day 1, postoperative day 2, postoperative day 3

    Measurement of systolic blood pressure (mmHg) during the resting period to evaluate hemodynamic stability.

  2. Change in Diastolic Blood Pressure

    Time frame: Preoperative, postoperative day 1, postoperative day 2, postoperative day 3.

    Measurement of diastolic blood pressure (mmHg) during the resting period to evaluate hemodynamic stability.

  3. Change in Respiratory Rate

    Time frame: Preoperative, postoperative day 1, postoperative day 2, postoperative day 3.

    Measurement of the number of breaths per minute to assess respiratory effort and function.

  4. Change in Pulse Rate

    Time frame: Preoperative, postoperative day 1, postoperative day 2, postoperative day 3.

    Measurement of the number of heartbeats per minute to monitor cardiovascular response.

Sponsors and collaborators

Lead sponsor

Cukurova University

Other

Registry information

Official study title

Outcomes of Incentive Spirometry for Patients Undergoing Coronary Artery Bypass Surgery: A Randomised Controlled Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 14, 2022
Registry last updated
Mar 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.